What is PETVIVO HOLDINGS INC's earnings per share (EPS)?

PETVIVO HOLDINGS INC (PETV) reported diluted earnings per share of -$0.38 for fiscal year 2026. This represents a 7.3% change compared to the previous fiscal year. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.

PETVIVO HOLDINGS INC (PETV) Financials

PETV

FY2026 annual

Revenue $1.1M +0.8% YoY

Net Income -$10.5M -24.7% YoY

EPS (Diluted) -$0.38 +7.3% YoY

Free Cash Flow -$6.1M -13.5% YoY

Market Cap $28.5M as of Oct 16, 2026

Price / Sales 24.1x on $1.2M revenue, trailing 12 months to June 30, 2026

Price / Earnings n/m net loss, so no earnings multiple, trailing 12 months to June 30, 2026

Price / Book 21.0x on $1.4M equity, Q1 FY2027

A multiple compares the market's price with a filed figure; it says what the market pays, not how the business is doing. The market capitalization is the vendor's as of Oct 16, 2026; every other figure is from the SEC filings on this page. Not financial advice.

Source SEC Filings (10-K/10-Q) Latest period Q1 FY2027, ended Jun 30, 2026 Reported Aug 14, 2026 Currency USD FYE March

Newest figures come from the 10-Q for Q1 FY2027, filed Aug 14, 2026. Each column of the statement tables below links to the filing it was taken from, and every filing is listed on the PETV SEC filings page.

PETVIVO HOLDINGS INC (PETV) reported $1.1M in revenue for fiscal year 2026, up 0.8% from the prior fiscal year. This page shows its income statement, balance sheet, cash flow statement, and key financial ratios. View 15 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Rhea AI PETV FY2026 2026-10-04

The development-stage business still relies on financing because sales do not yet cover operating investment.

Operating cash flow was -$6.1M and free cash flow was -$6.1M in FY2026, so capital spending was not the main drain. Financing cash flow of $6.1M nearly offset that operating need, linking reported funding to ongoing operations rather than internally generated cash.

Research and development was $1.4M against revenue of $1.1M in FY2026, so product investment exceeded the current sales base. That investment sat alongside a net loss of $10.5M, showing gross profit did not yet absorb the operating cost structure.

Revenue barely changed in the latest year, while gross margin compressed to 66.1% from 87.8%; the business generated less gross profit per sales dollar. Reported liquidity equaled one month of the latest annual operating outflow, leaving limited balance-sheet distance from its current spending pace.

Financial Health Signals

Financial health score not available

PETVIVO HOLDINGS INC does not currently provide enough eligible data for a peer-relative financial health score, so none is published. The signals and metrics below are current.

Altman Z-Score Distress

-35.19

PETVIVO HOLDINGS INC scores -35.19, below the 1.81 distress threshold. The score is driven primarily by a large market capitalization ($28.5M) relative to total liabilities ($1.4M). This indicates elevated financial distress risk and warrants close attention to liquidity and debt levels.

Distress-screening estimate for non-financial companies. Not computed for banks or insurers, where the Altman model does not apply.

Piotroski F-Score Partial

2/8

PETVIVO HOLDINGS INC passes 2 of 8 computable financial strength tests (1 of the nine could not be computed from available data). 1 of 4 profitability signals pass, no leverage/liquidity signals pass (rising debt, declining liquidity, or share dilution), 1 of 2 efficiency signals pass.

Earnings Quality No Cash Backing

N/A

PETVIVO HOLDINGS INC reported a net loss of $10.5M while operations used $6.1M of cash. With neither figure positive, the ratio between the two carries no quality signal.

Interest Coverage At Risk

N/A

PETVIVO HOLDINGS INC reported an operating loss of $9.1M against $13K in interest expense. There is no operating profit to cover interest, so interest must be met from cash reserves or from financing rather than from operations.

Key Financial Metrics

Export CSV

Earnings & Revenue

Revenue

$338K

YoY+13.5%

QoQ+32.5%

5Y CAGR+141.1%

PETVIVO HOLDINGS INC generated $338K in revenue in Q1 2027. This represents an increase of 13.5% from the same quarter a year earlier. Against the prior quarter it is up 32.5%.

EBITDA

-$1.5M

YoY+14.6%

QoQ+43.7%

PETVIVO HOLDINGS INC's EBITDA was -$1.5M in Q1 2027, measuring earnings before interest, taxes, depreciation, and amortization. This represents an increase of 14.6% from the same quarter a year earlier. Against the prior quarter it is up 43.7%.

Net Income

-$1.6M

YoY+30.2%

QoQ+45.5%

PETVIVO HOLDINGS INC reported -$1.6M in net income in Q1 2027. This represents an increase of 30.2% from the same quarter a year earlier. Against the prior quarter it is up 45.5%.

EPS (Diluted)

-$0.05

YoY+50.0%

QoQ+54.5%

PETVIVO HOLDINGS INC earned -$0.05 per diluted share (EPS) in Q1 2027. This represents an increase of 50.0% from the same quarter a year earlier. Against the prior quarter it is up 54.5%.

Cash & Balance Sheet

Free Cash Flow

-$978K

QoQ-20.4%

PETVIVO HOLDINGS INC recorded an outflow of $978K in free cash flow in Q1 2027, representing a cash shortfall after capex. Against the prior quarter it is down 20.4%.

Cash & Debt

$123K

YoY-96.3%

QoQ-38.9%

5Y CAGR-3.0%

10Y CAGR+72.6%

PETVIVO HOLDINGS INC held $123K in cash as of Q1 2027; long-term debt is not reported for that period.

Shares Outstanding

38M

YoY+55.6%

QoQ+0.9%

5Y CAGR+31.5%

PETVIVO HOLDINGS INC had 38M shares outstanding in Q1 2027. This represents an increase of 55.6% from the same quarter a year earlier. Against the prior quarter it is up 0.9%.

Dividends Per Share

Not reported for Q1 2027.

Margins & Returns

Gross Margin

66.1%

YoY+3.4pp

QoQ-13.7pp

5Y change+88.0pp

PETVIVO HOLDINGS INC's gross margin was 66.1% in Q1 2027, indicating the percentage of revenue retained after direct costs. This is up 3.4 percentage points from the same quarter a year earlier. Against the prior quarter it is down 13.7 percentage points.

Return on Equity

-119.0%

YoY-41.1pp

QoQ+15.7pp

PETVIVO HOLDINGS INC's ROE was -119.0% in Q1 2027, measuring profit generated per dollar of shareholder equity. This is down 41.1 percentage points from the same quarter a year earlier. Against the prior quarter it is up 15.7 percentage points.

Operating Margin

Not shown for Q1 2027: the reported ratio is below -100.0% of revenue, so it does not read as a share of revenue.

Net Margin

Not shown for Q1 2027: the reported ratio is below -100.0% of revenue, so it does not read as a share of revenue.

Capital Allocation

R&D Spending

$233K

YoY-31.5%

QoQ-52.4%

5Y CAGR+11.3%

PETVIVO HOLDINGS INC invested $233K in research and development in Q1 2027. This represents a decrease of 31.5% from the same quarter a year earlier. Against the prior quarter it is down 52.4%.

Capital Expenditures

$12K

PETVIVO HOLDINGS INC invested $12K in capex in Q1 2027, funding long-term assets and infrastructure.

Share Buybacks

Not reported for Q1 2027.

PETV Income Statement

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

PETV quarterly income statement

Metric	TTM	FY2610-K	FY2510-K	FY2410-K	FY2310-K	FY2210-K	FY2110-K	FY2010-K	FY1910-K	FY1810-K	FY1710-K	FY1610-K	FY1510-K	FY1310-K	FY1210-K	FY1110-K
Revenue	$1.2M	$1.1M+0.8%	$1.1M+16.9%	$969K+5.6%	$917K+693.5%	$116K+819.0%	$13K+250.6%	$4K	N/A	$2K-78.8%	$7K-90.5%	$75K	N/A	N/A	$0	$0
Cost of Revenue	$390K	$387K+181.0%	$138K+35.2%	$102K-53.9%	$221K+9.9%	$201K+1780.8%	$11K-45.7%	$20K-74.7%	$78K	N/A	N/A	N/A	N/A	N/A	$0	$0
Gross Profit	$791K	$755K-24.1%	$995K+14.8%	$867K+24.5%	$696K+913.5%	-$86K-4644.2%	$2K+111.7%	-$16K+79.3%	-$78K-5261.3%	$2K-78.8%	$7K-90.5%	$75K	N/A	N/A	$0	$0
R&D Expenses	$1.3M	$1.4M-10.6%	$1.6M+13.5%	$1.4M+40.0%	$996K+109.8%	$475K+383.4%	$98K+675.2%	$13K-93.7%	$201K+69.0%	$119K-29.2%	$168K-0.4%	$169K+3735.3%	$4K	N/A	$0	N/A
SG&A Expenses	$4.2M	$4.3M-10.2%	$4.8M-27.9%	$6.7M+33.3%	$5.0M+59.5%	$3.1M+78.1%	$1.8M-2.7%	$1.8M	N/A	$2.2M	N/A	$3.2M+163.7%	$1.2M	-$30K	N/A	N/A
Operating Income	-$8.8M	-$9.1M-12.5%	-$8.1M+24.2%	-$10.6M-21.6%	-$8.7M-72.7%	-$5.1M-158.1%	-$2.0M+2.8%	-$2.0M	N/A	-$2.3M	N/A	-$3.3M-170.5%	-$1.2M	N/A	N/A	N/A
EBITDA	N/A	-$8.6M-8.5%	-$7.9M+24.9%	-$10.5M-21.8%	-$8.6M-72.7%	-$5.0M-166.6%	-$1.9M-28.5%	-$1.5M	N/A	-$1.6M	N/A	-$2.5M	N/A	N/A	N/A	N/A
Interest Expense	-$104K	$13K+106.4%	$6K+195.0%	-$6K-140.8%	$16K+60.8%	$10K-95.7%	$229K+610.3%	$32K-62.1%	$85K+14.8%	$74K-60.7%	$189K-30.3%	$271K-32.2%	$399K	N/A	N/A	N/A
Net Income	-$9.8M	-$10.5M-24.7%	-$8.4M+23.3%	-$11.0M-25.7%	-$8.7M-73.8%	-$5.0M-42.4%	-$3.5M-69.1%	-$2.1M	N/A	-$2.3M	N/A	-$4.7M-202.2%	-$1.6M	-$86K	N/A	N/A
EPS (Basic)	N/A	-$0.38+7.3%	-$0.41+47.4%	-$0.78+8.2%	-$0.85-49.1%	-$0.570.0%	-$0.57	N/A	N/A	N/A	N/A	N/A	N/A	N/A	$0.00	$0.00
EPS (Diluted)	-$0.34	-$0.38+7.3%	-$0.41+47.4%	-$0.78+8.2%	-$0.85	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Diluted Shares (Avg)	N/A	30M+47.2%	20M+46.7%	14M+36.7%	10M	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A

Metric	Q1'2710-Q	Q4'2610-Q	Q3'2610-Q	Q2'2610-Q	Q1'2610-Q	Q4'2510-K	Q3'2510-Q	Q2'2510-Q
Revenue	$338K+13.5%	$255K+13.3%	$286K-51.0%	$303K+51.1%	$298K+140.4%	$225K+365.6%	$583K-2.1%	$201K-3.2%
Cost of Revenue	$114K+3.1%	$51K+22.5%	$141K+129.9%	$83K+293.3%	$111K+752.5%	$42K+725.9%	$61K-1.7%	$21K-3.2%
Gross Profit	$223K+19.6%	$203K+11.2%	$145K-72.3%	$220K+22.6%	$187K+68.6%	$183K+323.2%	$522K-2.2%	$180K-3.2%
R&D Expenses	$233K-31.5%	$490K+36.7%	$323K-13.2%	$261K-43.8%	$341K-12.1%	$359K-8.2%	$372K+5.8%	$465K+29.5%
SG&A Expenses	$967K-9.5%	$776K-31.8%	$1.3M+5.7%	$1.2M-2.4%	$1.1M-13.3%	$1.1M-41.8%	$1.2M-7.6%	$1.3M-25.1%
Operating Income	-$1.6M+12.8%	-$3.0M-42.4%	-$2.2M-24.6%	-$2.1M+5.0%	-$1.8M+9.8%	-$2.1M+21.5%	-$1.8M+17.6%	-$2.2M+26.2%
EBITDA	-$1.5M+14.6%	-$2.6M-30.6%	-$2.2M-26.1%	-$2.0M+5.1%	-$1.7M+14.1%	-$2.0M+23.4%	-$1.7M+17.9%	-$2.1M+26.5%
Interest Expense	$5K-95.9%	-$1.1M-177432.7%	$0-100.0%	$942K+38320.0%	$122K+4529.7%	$593	$461+122.0%	$2K+200.4%
Net Income	-$1.6M+30.2%	-$3.0M-22.5%	-$2.2M-24.7%	-$3.0M-38.3%	-$2.3M-12.9%	-$2.4M+8.7%	-$1.8M-0.4%	-$2.2M+40.6%
EPS (Basic)	-$0.05+50.0%	-$0.110.0%	-$0.07+22.2%	-$0.110.0%	-$0.10+9.1%	-$0.11+21.4%	-$0.09+25.0%	-$0.11+60.7%
EPS (Diluted)	-$0.05+50.0%	-$0.110.0%	-$0.07	-$0.110.0%	-$0.10+9.1%	-$0.11+21.4%	-$0.09+25.0%	-$0.11
Diluted Shares (Avg)	37M+52.5%	N/A	34M	28M+37.2%	24M+30.1%	N/A	21M+44.6%	20M

Not reported in any period shown, so not listed: Income Tax.

PETV Balance Sheet

PETV quarterly balance sheet

Metric	FY2610-K	FY2510-K	FY2410-K	FY2310-K	FY2210-K	FY2110-K	FY2010-K	FY1910-K	FY1810-K	FY1710-K	FY1610-K	FY1510-K	FY1310-K	FY1210-K	FY1110-K
Total Assets	$3.6M-61.7%	$9.3M+199.8%	$3.1M+27.7%	$2.4M-67.2%	$7.4M+789.2%	$835K+59.9%	$523K-24.4%	$691K-55.9%	$1.6M-17.4%	$1.9M-88.6%	$16.7M+2087.7%	$763K	$72K+5221.9%	$1K-63.8%	$4K
Current Assets	$1.7M-69.5%	$5.6M+438.5%	$1.0M-26.8%	$1.4M-78.9%	$6.8M+4490.7%	$147K-25.3%	$197K+253.3%	$56K-81.1%	$296K+764.9%	$34K-3.1%	$35K-87.2%	$275K	$2K+44.4%	$1K-63.8%	$4K
Cash & Equivalents	$201K-11.8%	$228K+160.5%	$87K-81.6%	$475K-92.2%	$6.1M+25800.5%	$24K+122.8%	$11K+63.8%	$6K-97.3%	$237K+833.1%	$25K+9758.1%	$258-99.4%	$40K	$721+220.4%	$225-78.9%	$1K
Short-Term Investments	$150K0.0%	$150K	$0	$0	$0	$0-100.0%	$2K	$0	$0	$0	$0	$0	$0	$0	$0
Inventory	$538K+66.4%	$324K-17.1%	$390K+5.3%	$370K+276.6%	$98K+165.9%	$37K-26.6%	$50K+303.0%	$12K-51.1%	$26K	N/A	N/A	N/A	N/A	N/A	N/A
Accounts Receivable	$101K+66.5%	$61K+224.5%	$19K-78.5%	$87K+3239.3%	$3K	N/A	$1K	N/A	$1630.0%	$163	N/A	N/A	N/A	N/A	N/A
Long-Term Investments	$150K	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0
Goodwill	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	$13.4M	N/A	N/A	N/A	N/A
Total Liabilities	$1.4M-73.1%	$5.1M+110.8%	$2.4M+41.7%	$1.7M+19.0%	$1.4M-16.8%	$1.7M+11.1%	$1.6M+1.5%	$1.5M+7.3%	$1.4M+32.9%	$1.1M-93.6%	$16.8M+2685.8%	$602K	$256K+43.3%	$179K+127.3%	$79K
Current Liabilities	$1.4M-68.1%	$4.3M+205.6%	$1.4M-2.8%	$1.5M+23.9%	$1.2M-16.5%	$1.4M+22.4%	$1.1M-25.3%	$1.5M+7.3%	$1.4M+32.9%	$1.1M-27.2%	$1.5M+145.8%	$602K	$256K+43.3%	$179K+127.3%	$79K
Non-Current Liabilities	$0-100.0%	$803K-21.0%	$1.0M+290.8%	$260K-2.6%	$267K-18.4%	$327K-20.4%	$411K	$0	$0	$0-100.0%	$15.3M	$0	$0	$0	$0
Total Equity	$2.2M-47.9%	$4.2M+515.1%	$686K-5.4%	$725K-87.9%	$6.0M+767.4%	-$897K+13.4%	-$1.0M-22.7%	-$845K-718.2%	$137K-83.3%	$820K+1265.6%	-$70K-143.6%	$161K	-$185K-3.9%	-$178K-136.9%	-$75K
Retained Earnings	-$101.3M-11.1%	-$91.2M-10.1%	-$82.8M-15.2%	-$71.8M-13.8%	-$63.1M-8.6%	-$58.1M-6.5%	-$54.6M-4.0%	-$52.5M-10.0%	-$47.7M-5.1%	-$45.4M-52.0%	-$29.9M-13.9%	-$26.2M	$121K+133.1%	-$366K-39.0%	-$263K

Metric	Q1'2710-Q	Q4'2610-Q	Q3'2610-Q	Q2'2610-Q	Q1'2610-Q	Q4'2510-K	Q3'2510-Q	Q2'2510-Q
Total Assets	$2.7M-61.3%	$3.6M-61.7%	$4.4M+40.6%	$5.3M+65.0%	$6.9M+138.5%	$9.3M+199.8%	$3.1M-14.3%	$3.2M-21.5%
Current Assets	$941K-78.6%	$1.7M-69.5%	$1.4M+12.8%	$2.1M+69.3%	$4.4M+400.1%	$5.6M+438.5%	$1.2M-17.8%	$1.2M-38.2%
Cash & Equivalents	$123K-96.3%	$201K-11.8%	$18K-37.1%	$768K+508.3%	$3.3M+26513.9%	$228K+160.5%	$29K-63.9%	$126K+128.5%
Short-Term Investments	$0	$150K0.0%	$0	$0	$0	$150K	$0	$0
Inventory	$451K-14.7%	$538K+66.4%	$605K+71.3%	$578K+55.4%	$529K+38.0%	$324K-17.1%	$353K-24.4%	$372K-14.3%
Accounts Receivable	$84K+222.9%	$101K+66.5%	$30K-93.9%	$138K+3.2%	$26K-64.0%	$61K+224.5%	$493K-4.9%	$134K-14.2%
Long-Term Investments	$150K	$150K	$0	$0	$0	$0	$0	$0
Total Liabilities	$1.3M-58.4%	$1.4M-73.1%	$997K-73.8%	$1.1M-61.3%	$3.2M+53.4%	$5.1M+110.8%	$3.8M+39.2%	$2.8M-9.6%
Current Liabilities	$1.3M-57.9%	$1.4M-68.1%	$988K-66.3%	$1.1M-43.3%	$3.1M+185.7%	$4.3M+205.6%	$2.9M+76.7%	$1.9M-3.0%
Non-Current Liabilities	$0-100.0%	$0-100.0%	$9K-99.0%	$23K-97.5%	$42K-95.7%	$803K-21.0%	$871K-18.8%	$920K-20.6%
Total Equity	$1.4M-54.3%	$2.2M-47.9%	$3.4M+586.3%	$4.2M+922.3%	$3.0M+257.8%	$4.2M+515.1%	-$695K-177.6%	$409K-58.6%
Retained Earnings	-$103.1M-10.2%	-$101.3M-11.1%	-$99.0M-11.5%	-$96.7M-11.1%	-$93.5M-10.2%	-$91.2M-10.1%	-$88.8M-10.8%	-$87.0M-11.0%

Not reported in any period shown, so not listed: Goodwill, Long-Term Debt.

PETV Cash Flow Statement

PETV quarterly cash flow statement

Metric	TTM	FY2610-K	FY2510-K	FY2410-K	FY2310-K	FY2210-K	FY2110-K	FY2010-K	FY1910-K	FY1810-K	FY1710-K	FY1610-K	FY1510-K	FY1310-K	FY1210-K	FY1110-K
Operating Cash Flow	-$5.4M	-$6.1M-14.8%	-$5.3M+28.3%	-$7.4M-9.2%	-$6.8M-62.7%	-$4.2M-444.2%	-$767K-54.0%	-$498K+32.4%	-$736K-28.0%	-$575K-302.2%	-$143K+79.3%	-$690K-73.2%	-$398K	-$71K	N/A	N/A
Depreciation & Amortization	N/A	$511K+192.9%	$175K+37.6%	$127K+10.8%	$114K+75.6%	$65K-24.9%	$87K-84.5%	$560K-13.5%	$647K+0.5%	$643K-13.9%	$747K+0.4%	$744K	N/A	N/A	N/A	N/A
Stock-Based Compensation	N/A	$1.9M+69.7%	$1.1M-47.5%	$2.1M+44.2%	$1.5M+108.1%	$703K+55.3%	$453K-47.5%	$863K-47.5%	$1.6M+90.5%	$863K+118.2%	$395K	N/A	N/A	N/A	N/A	N/A
Capital Expenditures	N/A	$8K-87.8%	$63K-79.5%	$309K-27.1%	$424K+175.2%	$154K+9.5%	$141K+329.0%	$33K+20.9%	$27K+41.4%	$19K-47.4%	$36K	N/A	N/A	N/A	N/A	N/A
Free Cash Flow	N/A	-$6.1M-13.5%	-$5.4M+30.3%	-$7.7M-7.1%	-$7.2M-66.7%	-$4.3M-376.8%	-$908K-71.0%	-$531K+30.5%	-$764K-28.5%	-$594K-231.2%	-$179K	N/A	N/A	N/A	N/A	N/A
Investing Cash Flow	N/A	$12K+102.1%	-$563K-82.3%	-$309K+27.1%	-$424K-131.4%	-$183K-14.4%	-$160K-151.5%	-$64K+38.6%	-$104K-65.0%	-$63K-72.5%	-$36K	N/A	-$388K	N/A	N/A	N/A
Financing Cash Flow	$2.3M	$6.1M+0.7%	$6.0M-17.9%	$7.3M+362.6%	$1.6M-84.8%	$10.4M+1010.4%	$940K+66.2%	$566K-7.1%	$609K-28.3%	$850K+315.4%	$205K-68.5%	$651K-17.3%	$787K	$72K	N/A	N/A

Metric	Q1'2710-Q	Q4'2610-Q	Q3'2610-Q	Q2'2610-Q	Q1'2610-Q	Q4'2510-K	Q3'2510-Q	Q2'2510-Q
Operating Cash Flow	-$966K+40.9%	-$812K+34.0%	-$1.5M-52.6%	-$2.2M-37.1%	-$1.6M-6.7%	-$1.2M+19.3%	-$961K+25.5%	-$1.6M+34.5%
Depreciation & Amortization	$135K+14.2%	$135K+78.0%	$15K-54.1%	$34K+3.6%	$118K+251.9%	$76K+129.1%	$32K+5.8%	$33K+2.6%
Stock-Based Compensation	$461K+245.8%	N/A	N/A	N/A	$133K-62.2%	N/A	N/A	N/A
Capital Expenditures	$12K	$0-100.0%	-$5K-78.0%	N/A	N/A	$21K-27.6%	$24K-87.3%	$3K-92.6%
Free Cash Flow	-$978K	-$812K+35.1%	-$1.5M-49.5%	N/A	N/A	-$1.3M+19.5%	-$985K+33.3%	-$1.6M+35.5%
Investing Cash Flow	-$12K	$0+100.0%	$5K+122.0%	N/A	N/A	-$521K-1678.7%	-$24K+87.3%	-$3K+92.6%
Financing Cash Flow	$900K-80.9%	$995K-49.0%	$712K-19.8%	-$348K-120.3%	$4.7M+220.3%	$1.9M+24.9%	$888K-40.9%	$1.7M-26.1%

Not reported in any period shown, so not listed: Dividends Paid, Share Buybacks.

PETV Financial Ratios

Margins and returns are percentages; the remaining ratios are unitless multiples. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

PETV quarterly financial ratios

Metric	FY2610-K	FY2510-K	FY2410-K	FY2310-K	FY2210-K	FY2110-K	FY2010-K	FY1910-K	FY1810-K	FY1710-K	FY1610-K	FY1510-K	FY1310-K	FY1210-K	FY1110-K
Gross Margin	66.1%-21.7pp	87.8%-1.7pp	89.5%+13.6pp	75.9%+149.9pp	-74.0%-89.0pp	15.0%	-449.3%	N/A	100.0%0.0pp	100.0%0.0pp	100.0%	N/A	N/A	N/A	N/A
Operating Margin	-793.9%	-711.3%	-1096.4%	-952.2%	-4374.7%	-15574.7%	-56191.0%	N/A	-151345.5%	N/A	-4334.9%	N/A	N/A	N/A	N/A
Net Margin	-917.5%	-741.6%	-1130.9%	-950.5%	-4338.8%	-28007.5%	-58047.2%	N/A	-154790.6%	N/A	-6307.7%	N/A	N/A	N/A	N/A
Return on Equity	-476.2%-277.1pp	-199.1%+1398.0pp	-1597.1%-394.7pp	-1202.4%-1118.6pp	-83.8%	N/A	N/A	N/A	-1710.5%	N/A	N/A	-970.9%	N/A	N/A	N/A
Return on Assets	-292.8%-202.9pp	-89.9%+261.7pp	-351.7%+5.8pp	-357.4%-289.9pp	-67.5%+354.2pp	-421.8%-23.2pp	-398.6%	N/A	-149.1%	N/A	-28.3%+176.9pp	-205.2%	-119.8%	N/A	N/A
Current Ratio	1.24-0.1x	1.30+0.6x	0.74-0.2x	0.98-4.8x	5.76+5.7x	0.10-0.1x	0.17+0.1x	0.04-0.2x	0.21+0.2x	0.030.0x	0.02-0.4x	0.46	0.010.0x	0.010.0x	0.05
Debt-to-Equity	0.63-0.6x	1.21-2.3x	3.54+1.2x	2.36+2.1x	0.24	N/A	N/A	N/A	10.47+9.2x	1.31	N/A	3.73	N/A	N/A	N/A
Asset Turnover	0.32+0.2x	0.12-0.2x	0.31-0.1x	0.38+0.4x	0.020.0x	0.020.0x	0.01	N/A	0.000.0x	0.000.0x	0.00	N/A	N/A	0.000.0x	0.00
FCF Margin	-535.6%	-475.5%	-797.8%	-787.0%	-3745.3%	-7217.8%	-14796.0%	N/A	-39366.0%	-2519.4%	N/A	N/A	N/A	N/A	N/A

Metric	Q1'2710-Q	Q4'2610-Q	Q3'2610-Q	Q2'2610-Q	Q1'2610-Q	Q4'2510-K	Q3'2510-Q	Q2'2510-Q
Gross Margin	66.1%+3.4pp	79.8%-1.5pp	50.6%-38.9pp	72.6%-16.9pp	62.8%-26.7pp	81.3%-8.2pp	89.5%0.0pp	89.5%0.0pp
Operating Margin	-476.6%	-1162.8%	-766.0%	-681.0%	-619.9%	-925.4%	-301.4%	-1082.6%
Net Margin	-478.1%	-1163.4%	-766.0%	-991.8%	-776.8%	-1076.6%	-301.2%	-1083.8%
Return on Equity	-119.0%-41.1pp	-134.7%-77.4pp	-64.9%	-71.9%+459.8pp	-77.9%+168.9pp	-57.3%+329.1pp	N/A	-531.7%-161.4pp
Return on Assets	-60.5%-26.9pp	-82.8%-56.9pp	-50.1%+6.4pp	-57.2%+11.1pp	-33.5%+37.3pp	-25.9%+59.2pp	-56.5%-8.2pp	-68.3%+21.9pp
Current Ratio	0.72-0.7x	1.24-0.1x	1.40+1.0x	2.00+1.3x	1.41+0.6x	1.30+0.6x	0.42-0.5x	0.67-0.4x
Debt-to-Equity	0.97-0.1x	0.63-0.6x	0.30	0.26-6.5x	1.06-1.4x	1.21-2.3x	N/A	6.79+3.7x
Asset Turnover	0.13+0.1x	0.070.0x	0.07-0.1x	0.060.0x	0.040.0x	0.020.0x	0.190.0x	0.060.0x
FCF Margin	-289.8%	-318.9%	-514.4%	N/A	N/A	-556.7%	-168.8%	-799.0%

Reported as filed but not readable as a share of revenue in the periods where the ratio runs further from zero than a revenue base allows; no change figure is given where either compared period is one of those: Operating Margin, Net Margin, FCF Margin.

Similar Companies

Newest fiscal year on record for each company. The health score is the peer-relative Financial Health Score for that year; a dash means no score is published for it.

Company	Fiscal year	Revenue	Net income	Net margin	Market cap	Health score
PETVIVO HOLDINGS INC PETV	FY2026	$1.1M	-$10.5M	N/A	$28.5M	—
GUIDED THERAPEUTCS INC GTHP	FY2025	$767K	-$3.2M	N/A	$18.3M	—
CS DIAGNOSTICS CORP CSDX	FY2024	N/A	$761	N/A	$100K	—
BIOTRICITY INC BTCY	FY2026	$16.0M	-$2.4M	-15.0%	N/A	—

Where PETVIVO HOLDINGS INC Ranks

Frequently Asked Questions

What is PETVIVO HOLDINGS INC's annual revenue?

PETVIVO HOLDINGS INC (PETV) reported $1.1M in total revenue for fiscal year 2026. This represents a 0.8% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.

How fast is PETVIVO HOLDINGS INC's revenue growing?

PETVIVO HOLDINGS INC (PETV) revenue grew by 0.8% year-over-year, from $1.1M to $1.1M in fiscal year 2026.

Is PETVIVO HOLDINGS INC profitable?

No, PETVIVO HOLDINGS INC (PETV) reported a net income of -$10.5M in fiscal year 2026.

What is PETVIVO HOLDINGS INC's EBITDA?

PETVIVO HOLDINGS INC (PETV) had EBITDA of -$8.6M in fiscal year 2026, measuring earnings before interest, taxes, depreciation, and amortization.

What is PETVIVO HOLDINGS INC's gross margin?

PETVIVO HOLDINGS INC (PETV) had a gross margin of 66.1% in fiscal year 2026, indicating the percentage of revenue retained after direct costs of goods sold.

What is PETVIVO HOLDINGS INC's return on equity (ROE)?

PETVIVO HOLDINGS INC (PETV) has a return on equity of -476.2% for fiscal year 2026, measuring how efficiently the company generates profit from shareholder equity.

What is PETVIVO HOLDINGS INC's free cash flow?

PETVIVO HOLDINGS INC (PETV) recorded an outflow of $6.1M in free cash flow during fiscal year 2026. This represents a -13.5% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.

What is PETVIVO HOLDINGS INC's operating cash flow?

PETVIVO HOLDINGS INC (PETV) recorded an outflow of $6.1M in operating cash flow during fiscal year 2026, representing cash used by core business activities.

What are PETVIVO HOLDINGS INC's total assets?

PETVIVO HOLDINGS INC (PETV) had $3.6M in total assets as of fiscal year 2026, including both current and long-term assets.

What are PETVIVO HOLDINGS INC's capital expenditures?

PETVIVO HOLDINGS INC (PETV) invested $8K in capital expenditures during fiscal year 2026, funding long-term assets and infrastructure.

How much does PETVIVO HOLDINGS INC spend on research and development?

PETVIVO HOLDINGS INC (PETV) invested $1.4M in research and development during fiscal year 2026.

How many shares does PETVIVO HOLDINGS INC have outstanding?

PETVIVO HOLDINGS INC (PETV) had 38M shares outstanding as of fiscal year 2026.

What is PETVIVO HOLDINGS INC's current ratio?

PETVIVO HOLDINGS INC (PETV) had a current ratio of 1.24 as of fiscal year 2026, which is considered adequate.

What is PETVIVO HOLDINGS INC's debt-to-equity ratio?

PETVIVO HOLDINGS INC (PETV) had a debt-to-equity ratio of 0.63 as of fiscal year 2026, measuring the company's financial leverage by comparing total debt to shareholder equity.

What is PETVIVO HOLDINGS INC's return on assets (ROA)?

PETVIVO HOLDINGS INC (PETV) had a return on assets of -292.8% for fiscal year 2026, measuring how efficiently the company uses its assets to generate profit.

What is PETVIVO HOLDINGS INC's P/E ratio?

PETVIVO HOLDINGS INC (PETV) has no price-to-earnings ratio at the moment: net loss, so no earnings multiple (trailing 12 months to June 30, 2026). The market capitalization is $28.5M as of Oct 16, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.

What is PETVIVO HOLDINGS INC's price-to-sales ratio?

PETVIVO HOLDINGS INC (PETV) trades at 24.1x sales, its market capitalization divided by revenue of $1.2M revenue, trailing 12 months to June 30, 2026. The market capitalization is $28.5M as of Oct 16, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.

How does PETVIVO HOLDINGS INC's liquidity compare with its operating cash outflow?

At the end of fiscal year 2026, PETVIVO HOLDINGS INC (PETV) held $501K in cash, cash equivalents and investments, and reported an operating cash outflow of $6.1M over that year. Dividing the one by the other, the reported balance equals about 1 month of the outflow reported that year. This is arithmetic over figures already filed, not a projection: it assumes nothing about future spending, financing or operations.

What is PETVIVO HOLDINGS INC's Altman Z-Score?

PETVIVO HOLDINGS INC (PETV) has an Altman Z-Score of -35.19, placing it in the Distress Zone (elevated bankruptcy risk). The Z-Score combines five financial ratios (working capital, retained earnings, EBIT, market capitalization, and revenue relative to total assets) to predict the likelihood of bankruptcy. Scores above 2.99 indicate financial safety while scores below 1.81 suggest financial distress. Learn more in our complete guide to financial health indicators.

What is PETVIVO HOLDINGS INC's Piotroski F-Score?

PETVIVO HOLDINGS INC (PETV) has a Piotroski F-Score of 2 out of 8 computable signals; 1 of the nine could not be computed from available data, so the full-scale strength rating is not shown. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.

Are PETVIVO HOLDINGS INC's earnings high quality?

PETVIVO HOLDINGS INC (PETV) reported a net loss of $10.5M while operations used $6.1M of cash. With neither figure positive, the ratio between the two carries no quality signal. This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.

Can PETVIVO HOLDINGS INC cover its interest payments?

PETVIVO HOLDINGS INC (PETV) reported an operating loss of $9.1M against $13K in interest expense. There is no operating profit to cover interest, so interest must be met from cash reserves or from financing rather than from operations. This ratio divides operating income by interest expense. Ratios above 5x indicate strong debt-servicing ability, while ratios below 2x suggest the company may face difficulty meeting interest payments if earnings decline. Learn more in our complete guide to financial health indicators.